Daily Archives: September 7, 2022

An upcoming webinar this month is aiming to demystify the complexities associated with the expanding clinical psychedelic industry.

On Wednesday, Xtalks announced that it would be hosting an upcoming online event entitled Psychedelic Research: Demystifying Complex Operations.

The educational webinar provider says the recent resurgence of interest in psychedelics inherently poses new challenges. Conducting responsible science and executing efficient clinical trials with previously researched psychoactive molecules in a modern-day regulatory environment are examples.

Read more:Field Trip facilitates beneficial psychedelic-assisted therapy for cancer patient

Read more:Filament administers psilocybin to 14 participants in Health Canada sanctioned clinical trial

For the upcoming free webinar on September 27, those in attendance will be educated by a panel of psychedelic operational experts from Xtalks partnerWorldwide Clinical Trials on properly navigating the challenging considerations required for undertaking clinical trials.

Xtalks says that attendees will also be taught how to select appropriate participants for clinical research, navigate current regulatory frameworks and acquire mandatory licenses.

For sponsors, investigators and regulators, psychedelics pose new clinical trial considerations. Dosing patients with these investigational products requires careful selection of both the clinical site, supportive therapists, efficacy raters and the patient themselves. Trust and support are paramount in this unique research partnership.

Xtalks specializes in providing informative webinars regarding medical devices, food and global life sciences. The organization says that it helps keep professionals updated on industry trends, regulations and developments.

Its partner for the upcoming webinar, Worldwide Clinical Trials, is a contract research organization (CRO) established in 1986 that specializes in neuroscience, oncology, general medicine and rare diseases.

We are clinicians, scientists, researchers, and tech wizards who facilitate the development of life-changing medicines.

Follow Mugglehead on Twitter

Like Mugglehead on Facebook

Go here to see the original:

Xtalks to host upcoming webinar on psychedelic know-how - Mugglehead

Take a trip to Psychedelics: The Experiential Exhibition,the first immersive art show in Canada to explore the past, present, and future of psychedelics.

Delving into societys complex and controversial relationship with psychedelics, the exhibition utilizes a unique audiovisual edutainment experience.

Set to open on September 30, the show will span three floors within Torontos Lithuanian House. It will feature a 12,000-square-foot collection of curated artifacts and original installations by more than 22 artists.

Were seeing significant change in the way psychedelic substances are used and perceived, said James Drayton, producer of Psychedelics: The Experiential Exhibition.

My goal with the show is to, first and foremost, provide guests with an entertaining and eye-opening experience. My hope is that it also encourages learning, dialogue, and ultimately, destigmatization.

Bioworkz

Visitors will be guided through a series of curated spaces, each devoted to a different psychedelic substance and its historical or traditional uses.

Discover the psychoactive brew consumed in the Eleusinian Mysteries of Ancient Greece, and open your mind to the role of ayahuasca in Indigenous religious ceremonies in South America.

Take a trip through the Acid Tests and experimentation of the psychedelic 60s and explore LSDs current role as a promising therapy for intractable mental health conditions.

Highlights of the exhibition include an immersive peyote installation with massive hypnotic murals by Clandestinos, and a fantastical video triptych by Alex McLeod, which will be projected into a space exploring the history and renewed popularity of psilocybin.

The show will also feature a recreation of a 1960s Bay Area Acid Test, with mesmerizing liquid light visuals by Brotherhood of Light and Liquid Light Lab, former collaborators of the Allman Brothers and Grateful Dead.

The grand finale will be a fully immersive audiovisual installation by director and designer GMUNK.

Psychedelics: The Experiential Exhibition

Visitors are guided through a nine-minute ayahuasca ceremony thats channeled via a shamanic totem. Featuring lights, sounds, lasers, and projection mapping of a fully activated light sculpture, producers note its best experienced rather than described.

Until recently, the lively culture of psychedelic research and experimentation was forced underground, a release for the show reads.

Psychedelics: The Experiential Exhibition celebrates its recent renaissance while contemplating its future potential. Prepare to have your mind expanded.

When:Wednesdays through Sundays from September 30 to October 30

Where:Lithuanian House, 1573 Bloor Street West

Tickets: Available online | Starting at $30

Go here to see the original:

An immersive psychedelic exhibition is opening in Toronto this month | Listed - Daily Hive

Journalist Michael Pollan is the author of How to Change Your Mind. This is a fascinating book on the history of psychedelic drugs. The book follows the rise, fall and recent return of psychedelic research while examining the changing of their public and professional perception.

Recently, Netflix has also released a documentary series based on Pollans book that includes testimonials from people who have actually undergone the monitored experiment and talk about the various psychedelic benefits, that have changed their lives for the better.

If you were to take a walk down the streets, wouldnt you like to see more happy faces around you? People being calm, minding their own business, no frowns, no one having a panic attack right next to you in the bus Wouldnt that be nice? Most of you would say Of course, but that would happen in an ideal world and we dont live in one.

Some psychiatrists, neuro psychiatrists and psychologists, have studied the effects of psychedelics and their benefits when administered in a controlled environment, strictly for medical purposes. Although most psychedelics remain illegal under federal law, the FDA is weighing potential therapeutic uses for substances like psilocybin, LSD and MDMA (which is also known as Ecstasy).

To give you a broad kind of definition, the term psychedelic comes from the Greek psyche and delos so its translated to mind-manifesting. But not all psychedelics have the same action mechanism.

What if we could change our mindset and see these substances for the benefits that they can have on certain mental disorders? What if mental problems such as PTSD, alcoholism and depression could be cured by substances such as mescaline, psilocybin, MDMA or even LSD?

Lets find out more about these four substances and how they can be used in our advantage.

Probably many of you have heard scary things about LSD use. But the truth is that this is one of the least dangerous or addictive psychoactive drugs. However, this doesnt mean there is no risk in using it for personal entertainment. In fact, all the drugs in this list may have potential benefits but ONLY under monitored sessions where professionals can guide you and administer you the right dose.

More than 60 years ago, Albert Hofmann has first synthesized LSD from a fungus called ergot. LSD was first created with the intention to cure women with postnatal depression

Between 1950-1965, thousands of scientific articles about psychedelics were released, explaining their benefits from a medical point of view. However, like any other drug, LSD got into the hands of the wrong people and was distributed at parties, music festivals, and the results were catastrophic. Needless to say that the drug was soon banned from the market as it was considered an illicit drug.

Although professors from prestigious Universities tried to explain that microdoses of LSD can seriously alleviate symptoms of depression, anxiety, PTSD, and can help with problem solving issues, the drug has still remained illicit.

However, in the early 2000s, research slowly began to pick back up.

How astounding is that a substance called Psilocybin, found in a little mushroom can ameliorate the suffering of those who have cancer. Psilocybin can have a positive impact on their emotional and psychological distress which takes away from their quality of life.

A research was conducted on participants brains to actually see what happens at a neuro level after ingesting small doses of Psilocybin. Researchers have discovered that psychedelics work on the Default Mode Network the part houses the self and the assumptions about the self, the stories we tell ourselves

There are two kinds of science. The one that wants to look at only what can easily be measured and ignore everything else. And then theres the true science that proves the very frontiers of human knowledge, and that is where psychedelic research is right now.

Another small study on the therapeutic effects of using psychedelics to treat alcoholism found that just two doses of psilocybin magic mushrooms combined with psychotherapy led to an 83% decline in heavy drinking among the participants. After eight months, nearly half of those who received psilocybin had stopped drinking entirely.

The study published in JAMA Psychiatry has also talked about the benefits ofPsilocybin on a range of mental health problems, from depression, anxiety, PTSD and OCD.

MDMA (aka Ecstasy) is a synthetic drug that was first developed in 1912 and it was intended to control bleeding in hospital patients. Later, researchers have found that the drug also helped in enhancing communication in patient sessions and allowed them to achieve insights about their problems.

MDMA causes a flood of serotonin and oxytocin and that creates a feeling of openness, of loving connection to others. These feelings help reduce symptoms of depression and anxiety. Research also shows that in controlled doses paired with therapy, MDMA has positive effects on PTSD and on victims that were sexually abused.

Mescaline is a chemical substance that develops in two types of cactuses.It is said that it treats anxiety, depression and certain addictions such as alcoholism.

Mescaline was first used in the traditional ceremonies of Indigenous American cultures. The Natives have known of the plants hallucinatory and medicinal properties for thousands of years, and peyote still holds a sacred place in their culture. In fact, over 40 tribes in North America and Western Canada still use it in their sacred ceremonies.

Mescaline and peyote are now banned under United States drug laws, but such ceremonial use is exempted.

Mental health care is in crisis. We have rising rates of depression, suicide, anxiety, eating disorders, addictions, PTSD and OCD.

The studies comprised in Michael Pollans book How to Change Your Mind, suggest that psychedelics may have huge benefits on mental health if used properly and only under medical supervision.

As odd as it seems some of them can be effective for multiple forms of addiction, which is great news for those battling substance abuse.

However, keep in mind that this article is designed to inform. We do not provide medical advice. You should always consult a professional or a doctor before starting any type of treatment.

See original here:

Netflixs How to Change Your Mind Says Drugs Are the Answer Are They Right? - Goalcast

The 2022 NFL season is set to begin on Thursday night with the defending Super Bowl champion Los Angeles Rams hosting this years odds-on-favorite, the Buffalo Bills.

One thing that doesnt seem to change is Green Bay Packers quarterback Aaron Rodgers saying something wild and outlandish. The back-to-back NFL MVP has been at the center of controversy concerning his unvaccinated status, retirement threats and now his using psychedelics as a way of life.

During a recent interview on his good buddy Pat McAfees popular show, Rodgers made it known that his use of ayahuasca has given him a newfound love for life and the game of football.

Ive been enjoying football since I did ayahuasca. So the last few years have been great.

McAfee then wanted to know more.

Then well talk about ayahuasca, because Ive got a lot of questions. Your love of football though, since ayahuasca, why? New mindset, new vision on things, new look at things? Well, how come?

Rodgers quickly responded:

Yeah, mental health, bro. It starts out self-love, and when you increase that, then youre able to pass that on more easily. And listen, the locker room is where the chemistry takes place. Theres a lot of great things that happen on the practice field, and obviously in the game, and outside the facility is fun, and dinners and different things. But the locker room, thats the core of the connection.

Sounds like Rodgers is really comfortable where he is in life, both on and off the gridiron. He was just singing a different tune a few weeks ago as he complained about his receivers needing to step up and play better.

Rodgers Credits Back-To-Back MVPs From Ayahuasca Use

In early August Rodgers appeared on the Aubrey Marcus Podcast and said he believes its no coincidence that his back-to-back MVP seasons came after he began taking the plant-based psychedelic. He mentioned how his mental health improved and how it played a huge role in his changed mindset.

I dont think its a coincidence. I really dont. I dont really believe in coincidences at this point. Its the universe bringing things to happen when theyre supposed to happen.

Theres signs and synchronicities all around us at all times of were awake enough to see them and to take them in and listen to our intuition when its speaking to us or pounding us in the head saying, Hey, dummy, this is what youre supposed to be doing.

Rodgers proceeded to tell Marcus the decision to take ayahuasca stemmed from his previously delving into psychedelics. Hed go on to say one of the best days of life involved him consuming shrooms on the beach. He said he felt himself merge with the ocean following consumption.

Rodgers Looks For Third Consecutive MVP: But Without Top Target Davante Adams

Over the past two seasons, Rodgers passed for 8,414 yards, 85 touchdowns and just nine interceptions. But hell need to replace the 2,926 yards and 29 touchdowns that Davante Adams took with him to Las Vegas in the March blockbuster trade. While that will be nearly impossible, Rodgers will be forced to lean heavily on his running game and strong defense and maybe some psychedelics

Read More TSL Stories:

Cam Newtons Ex Takes Him To Court, Claims He Reneged On Deal To Pay $20K In Utilities | Them Bills Hits Different When NFL Checks Dry Up The Shadow League

Its Officially Savage Season | Tyreek Hill Becomes Second NFL Player To Slide In Jake Pauls Girlfriends DMs The Shadow League

Follow this link:

Yeah, Mental Health, Bro, It Starts With Self-Love | Aaron Rodgers Says His Use Of Psychedelics Has Increased His Passion For Life And The Game Of...

World Biz Magazine's Top 100 CEOs in Innovation list recognizes individuals who exhibit exceptional leadership and vision while making invaluable contributions to their industries.

VANCOUVER, BC, Sept. 7, 2022 /PRNewswire/ -Delic Holdings Corp ("Delic" or the "Company") (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, today celebrated Matt Stang, recently named Executive Chairman of Delic Corp, as one of World Biz Magazine's Top 100 CEOs in Innovation in 2022. Stang has been recognized as a champion of creativity who is committed to making a positive environmental and social impact through his work.

Matt Stang, CEO & Co-founder, Delic Corp (CNW Group/Delic Holdings Inc.)

Stang co-founded and grew Delic Corp into the nation's largest ketamine therapy provider. Under his leadership, the Company acquired Ketamine Wellness Centers (KWC), generated more than USD$1.5MM in total revenue in 2021 and more than quadrupled its net assets. Stang's ability to elevate the Company's ability to offer premium quality treatments to patients allowed him to transition from CEO to executive chairman in August 2022. In this position, Stang will continue to lead the Company in its mission to revolutionize healthcare.

"It is an honor to be recognized by World Biz Magazine as one of the foremost innovators in healthcare today. With the help of my talented team at Delic Corp, we continue to make safe, affordable treatments more accessible to patients across the country," Stang commented. "I firmly believe that our company's work is bettering the lives of people and communities every day. I am proud to be a part of this team and am truly excited to see what the future holds."

To learn more about Matt Stang's inclusion on World Biz Magazine's Top 100 CEOs in Innovation list, please visit http://www.worldbizmagazine.net.

About Delic Corp

Delicis a leader in new medicines and treatments for a modern world, improving access to health benefits across the country and reframing the conversation on psychedelics. The company owns and operates an umbrella of related businesses, including the largest chain of psychedelic wellness clinics in the country, Ketamine Wellness Centers; the only licensed entity by Health Canada to focus exclusively on research and development of psilocybin vaporization technology,Delic Labs; the premier psychedelic wellness event, Meet Delic; and trusted media and e-commerce platforms Reality SandwichandDelic Radio. Delic is backed by a team of industry and cannabis veterans and a diverse network, whose mission is to provide education, research, high-quality products, and better access to effective and affordable treatment options.

Story continues

Forward-Looking Information and Statements

This press release contains certain "forward-looking information" within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company's beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of Delic's control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or may contain statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "will continue", "will occur" or "will be achieved". The forward-looking information and forward-looking statements contained herein may include, but are not limited to: information regarding the timing or terms upon which the Transaction will be completed; potential benefits of the Transaction; anticipated continued growth in the health and wellness sector (and, in particular, related to psychedelics); the ability of Delic to successfully achieve business objectives, and expectations for other economic, business, and/or competitive factors.

By identifying such information and statements in this manner, Delic is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Delic to be materially different from those expressed or implied by such information and statements. Such risks and other factors may include, but are not limited to: risks and uncertainties relating to the Transaction not closing as planned or at all or on terms and conditions set forth in the Merger Agreement; incorrect assessment of the value and potential benefits of the Transaction; direct and indirect material adverse effects from the COVID-19 pandemic; inability to obtain future financing on suitable terms; failure to obtain required regulatory and other approvals; risks inherent in the psychedelic treatment sector; changes in applicable laws and regulations; and failure to comply with applicable laws and regulations.

In addition, in connection with the forward-looking information and forward-looking statements contained in this press release, Delic has made certain assumptions. These assumptions include, but are not limited to: assumptions as to the time required to negotiate a definite agreement and complete matters related to the Transaction; the ability to consummate the Transaction; the ability of the parties to obtain, in a timely manner, the requisite regulatory, corporate and other third party approvals and the satisfaction of other conditions to the consummation of the Transaction on the proposed terms; the potential impact of the announcement or consummation of the Transaction on relationships, including with regulatory bodies, employees, suppliers, customers and competitors; changes in general economic, business and political conditions, including changes in the financial markets; changes in applicable laws; compliance with extensive government regulation; and the diversion of management time on the Transaction.

Should one or more of these risks, uncertainties or other factors materialize, or should assumptions underlying the forward-looking information or statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected.

Although Delic believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and Delic does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to Delic or persons acting on its behalf is expressly qualified in its entirety by this notice.

Delic Logo (CNW Group/Delic Holdings Inc.)

Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/delic-executive-chairman-matt-stang-named-to-world-biz-magazines-top-100-ceos-in-innovation-301619157.html

SOURCE Delic Holdings Inc.

Link:

Delic Executive Chairman Matt Stang Named to World Biz Magazine's Top 100 CEOs in Innovation - Yahoo Finance

A recent study disclosed how younger generations are experimenting with cannabis and hallucinogenic use at the highest levels according to data from previous years.

In a recent piece by NPR (1), it was reported that younger generations are experimenting with cannabis and hallucinogenic use more than ever before. In a study from the National Institutes of Health (NIH), participants between the ages of 19 to 30 reported using one or the other, which showed cannabis and hallucinogens at their highest rates since 1988 (2).

"Young adults are in a critical life stage and honing their ability to make informed choices," said Dr. Nora Volkow, the director of the National Institute on Drug Abuse, a NIH subsidiary (2). "Understanding how substance use can impact the formative choices in young adulthood is critical to help position the new generations for success.

According to reports, the most recent data was collected from AprilOctober 2021, as outlined in more detail below.

Cannabis

Young adult users reported in 2021 that they used cannabis in the past month (29%), daily use (11%), or in the past year (43%), which were the uppermost levels ever to be recorded. The study defined daily use to be 20 or more times within 30 days, and this data was up from 8% in 2016. Cannabis vape users who had vaped in the past month reached pre-pandemic levels. In 2017, vaping was reported at 6% which then doubled to 12% in 2021.

Hallucinogens

Over the past few decades, hallucinogenic use for youths had been somewhat consistent. During the pandemic in 2020, those rates began to rise. In 2021, 8% of young adults reported having taken a hallucinogen in the past year. This was the largest spike seen since the survey was created in 1988.

The hallucinogens users reported were lysergic acid diethylamide (LSD), mescaline, peyote, mushrooms (shrooms), phencyclidine (PCP), and 3,4-Methylenedioxymethamphetamine (MDMA) which is also known as ecstasy or molly. MDMA use was the only hallucinogen to decrease, from 5% in 2020 to 3% in 2021.

Additional Substances

The most popular of substances mentioned in the survey was alcohol. Over the past decade, daily drinking rates have decreased. Binge drinking though (NIH describes binge drinking as consuming five or more drinks in a row in the past 2 weeks) is seeing levels rise despite reaching a historic low in 2020, the beginning of the COVID-19 pandemic (2).

Another form of alcohol use is high-intensity drinking, which the NIH defines as having 10 or more drinks in a row within the past two weeks, has been steadily increasing over the last 10 years. In 2021, high-intensity drinking was at its highest level since 2005.

Although the dangers of vaping are becoming more well-known, nicotine vapes are still gaining popularity with todays youth. It was first measured in 2017 at 6% but has tripled in 2021 to 16%. Interestingly, opioids and nicotine cigarettes have been declining over the last decade (1,3).

Conclusion

Despite concerns, there is valid research going on for the benefits of using these substances, particularly related to mental health concerns brought on by the pandemic. There are many questions still to be addressed, making it clear that more research is needed. Please read our supplemental digital issue on psychedelics to learn more about some of the research efforts taking place: https://www.cannabissciencetech.com/journals/cannabis-science-and-technology/psychedelics-new-frontiers-in-alternative-medicine

If youd like to learn more about this study, please visit: https://www.npr.org/2022/08/24/1119191104/marijuana-hallucinogens-use-young-adults

References

Go here to see the original:

Cannabis and Hallucinogens Are Being Consumed at the Highest Rates on Record by Today's Young Adults - Cannabis Science and Technology